Gastroenterology
Volume 135, Issue 4 , Pages 1185-1191 , October 2008

Efficacy of Serologic Marker Screening in Identifying Hepatitis B Virus Infection in Organ, Tissue, and Cell Donors

  • Dominique Challine

      Affiliations

    • French National Reference Center for Viral Hepatitis B, C and Delta, Department of Virology, Hôpital Henri Mondor, Université Paris 12, Créteil, France
    • Viral Emergency and Organ, Tissue and Cell Donor Screening Laboratory, Hôpital Henri Mondor, Université Paris 12, Créteil, France
    • INSERM U841, Créteil, France
    • ,
  • Stéphane Chevaliez

      Affiliations

    • French National Reference Center for Viral Hepatitis B, C and Delta, Department of Virology, Hôpital Henri Mondor, Université Paris 12, Créteil, France
    • INSERM U841, Créteil, France
    • ,
  • Jean–Michel Pawlotsky

      Affiliations

    • French National Reference Center for Viral Hepatitis B, C and Delta, Department of Virology, Hôpital Henri Mondor, Université Paris 12, Créteil, France
    • Viral Emergency and Organ, Tissue and Cell Donor Screening Laboratory, Hôpital Henri Mondor, Université Paris 12, Créteil, France
    • INSERM U841, Créteil, France
    • Corresponding Author InformationCorresponding author: Professor Jean–Michel Pawlotsky, MD, PhD, Department of Virology, Hôpital Henri Mondor, 51 Avenue du Maréchal de Lattre de Tassigny, 94010 Créteil, France. fax: (33) 1-4981-4831

Received 20 March 2008 ,Accepted 10 July 2008.

References 

  1. Alter MJ. Epidemiology and prevention of hepatitis B. Semin Liver Dis. 2003;23:39–46
  2. Eastlund T. Infectious disease transmission through cell, tissue, and organ transplantation: reducing the risk through donor selection. Cell Transplant. 1995;4:455–477
  3. Locasciulli A, Alberti A, Bandini G, et al. Allogeneic bone marrow transplantation from HBsAg+ donors: a multicenter study from the Gruppo Italiano Trapianto di Midollo Osseo (GITMO). Blood. 1995;86:3236–3240
  4. Hoft RH, Pflugfelder SC, Forster RK, et al. Clinical evidence for hepatitis B transmission resulting from corneal transplantation. Cornea. 1997;16:132–137
  5. Natov SN, Pereira BJ. Transmission of viral hepatitis by kidney transplantation: donor evaluation and transplant policies (part 1: hepatitis B virus). Transpl Infect Dis. 2002;4:117–123
  6. Francisci D, Aversa F, Coricelli V, et al. Prevalence, incidence and clinical outcome of hepatitis B virus and hepatitis C virus hepatitis in patients undergoing allogeneic hematopoietic stem cell transplantation between 2001 and 2004. Haematologica. 2006;91:980–982
  7. Wachs ME, Amend WJ, Ascher NL, et al. The risk of transmission of hepatitis B from HBsAg(−), HBcAb(+), HBIgM(−) organ donors. Transplantation. 1995;59:230–234
  8. Roche B, Samuel D, Gigou M, et al. De novo and apparent de novo hepatitis B virus infection after liver transplantation. J Hepatol. 1997;26:517–526
  9. Dickson RC, Everhart JE, Lake JR, et al. Transmission of hepatitis B by transplantation of livers from donors positive for antibody to hepatitis B core antigen (The National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database). Gastroenterology. 1997;113:1668–1674
  10. De Feo TM, Poli F, Mozzi F, et al. Risk of transmission of hepatitis B virus from anti-HBc positive cadaveric organ donors: a collaborative study. Transplant Proc. 2005;37:1238–1239
  11. Chazouilleres O, Mamish D, Kim M, et al. “Occult” hepatitis B virus as source of infection in liver transplant recipients. Lancet. 1994;343:142–146
  12. Challine D, Roudot-Thoraval F, Sabatier P, et al. Serological viral testing of cadaveric cornea donors. Transplantation. 2006;82:788–793
  13. Zou S, Dodd RY, Stramer SL, et al. Probability of viremia with HBV, HCV, HIV, and HTLV among tissue donors in the United States. N Engl J Med. 2004;351:751–759
  14. Lefrere JJ, Sellami F, Larderie P, et al. Six years' experience testing organ donors for viral markers in France. Transfusion. 1997;37:565–566
  15. Tugwell BD, Patel PR, Williams IT, et al. Transmission of hepatitis C virus to several organ and tissue recipients from an antibody-negative donor. Ann Intern Med. 2005;143:648–654
  16. Challine D, Pellegrin B, Bouvier-Alias M, et al. HIV and hepatitis C virus RNA in seronegative organ and tissue donors. Lancet. 2004;364:1611–1612
  17. Stuyver L, De Gendt S, Van Geyt C, et al. A new genotype of hepatitis B virus: complete genome and phylogenetic relatedness. J Gen Virol. 2000;81:67–74
  18. Tiollais P, Pourcel C, Dejean A. The hepatitis B virus. Nature. 1985;317:489–495
  19. Vyas GN, Rao KR, Ibrahim AB. Australia antigen (hepatitis B antigen): a conformational antigen dependent on disulfide bonds. Science. 1972;178:1300–1301
  20. Carman WF, Van Deursen FJ, Mimms LT, et al. The prevalence of surface antigen variants of hepatitis B virus in Papua New Guinea, South Africa, and Sardinia. Hepatology. 1997;26:1658–1666
  21. Weber B. Genetic variability of the S gene of hepatitis B virus: clinical and diagnostic impact. J Clin Virol. 2005;32:102–112
  22. Tordjeman M, Fontan G, Rabillon V, et al. Characterization of minor and major antigenic regions within the hepatitis B virus nucleocapsid. J Med Virol. 1993;41:221–229
  23. Chang TT, Gish RG, de Man R, et al. A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B. N Engl J Med. 2006;354:1001–1010
  24. Lai CL, Shouval D, Lok AS, et al. Entecavir versus lamivudine for patients with HBeAg-negative chronic hepatitis B. N Engl J Med. 2006;354:1011–1020
  25. Chen CJ, Yang HI, Su J, et al. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA. 2006;295:65–73

 D.C. and S.C. participated equally in this study.

 The Cobas TaqMan HBV kits were kindly provided by Roche Molecular Systems (Pleasanton, CA).

PII: S0016-5085(08)01319-X

doi: 10.1053/j.gastro.2008.07.011

Gastroenterology
Volume 135, Issue 4 , Pages 1185-1191 , October 2008

Article Tools

* Image Usage & Resolution